Over the last 4 or
5 years, more and more diseases are described in which fetal cells are
found at the site of autoimmune maternal disease and more recently
maternal cells are being found at the site of newborn destructive
(“graft-versus-host”) diseases. Many diseases including systemic
sclerosis and fetal dermatomyostis have
now been attributed to fetal-maternal
microchimerism. The report by
Klinschar et al adds to the evidence that Hashimoto’s
thyroiditis includes fetal microchimerism
in the fetal thyroid gland. These authors took thyroid gland
specimens, extracted DNA, and then used Y probes to look for evidence
of male cells in the maternal thyroids. They specifically used
thyroid glands from women who had male children, and found
evidence of male microchimerism in half
the specimens. Among the controls (nodular goiter), only 1/25
specimens had evidence of Y chromosome
microchimerism.
The importance of
this observation is related to the question of whether the fetal cells
can be a cause of autoimmune diseases since there is an excess of
thyroid autoimmune disorders in females. The molecular
techniques presently used look for Y DNA probes in females and female
cells in males. The new molecular techniques allow this sort of
recognition. It seems likely that all of us carry some maternal
stem cells and that women who have been
pregnant carry fetal cells, which can respond to damage and stress.
What is not clear is whether the fetal cells are the cause of auto
immunity or simply represent a stem cell response to injury.
Editor’s Comment:
It will be important
to look at multiple tissues for fetal cells. It appears that
pregnancies which have been complicated are more likely to have fetal
cells in circulation. Thus, pre-eclampsia
and anueploidy are known to have increased
trafficking between mother and fetus. In addition, loss of
co-twins can predispose to microchimerism.
Keep your eyes open for more work in this area since it is highly
likely that additional papers will try to discriminate the source of
the cells, and determine the time at which they would have migrated to
specific tissues.
Judith G. Hall,
OC,
MD
Click here to view Table